Tokushima, Japan

Tatsuya Uji


Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tatsuya Uji in Pharmacy

Introduction

Tatsuya Uji, an accomplished inventor based in Tokushima, Japan, has made significant strides in the field of pharmaceutical sciences. With two notable patents to his name, Uji's work primarily focuses on developing compounds that enhance the efficacy of antibiotics against resistant bacterial strains.

Latest Patents

Uji's latest patents include innovative azetidinone derivatives designed as beta-lactamase inhibitors. His research has resulted in the development of new 2-oxo-1-azetidine sulfonic acid derivatives, which possess an aminoalkyl substituted 'anti' (E-isomer) oxyimino group at the 3 position of the monobactam ring. These compounds have proven to be potent inhibitors of bacterial beta-lactamases.

By using these compounds in conjunction with beta-lactam antibiotics, the effectiveness of these antibiotics is significantly enhanced, particularly in treating infections caused by beta-lactamase producing bacteria. Another key patent revolves around similar 2-oxo-1-azetidine sulfonic acid derivatives that showcase their ability to act as potent beta-lactamase inhibitors.

Career Highlights

Throughout his career, Uji has been associated with renowned pharmaceutical companies such as Synphar Laboratories, Inc. and Taiho Pharmaceutical Company Limited. His work in these institutions has allowed him to explore and innovate new therapeutic avenues, particularly in antibiotic resistance.

Collaborations

Uji has collaborated with esteemed colleagues including Samarendra N. Maiti and Oludotun A. Phillips. These collaborations have fostered an environment of innovation and research, leading to impactful advancements in pharmacological applications.

Conclusion

In conclusion, Tatsuya Uji stands out as a significant inventor in the pharmaceutical realm, whose contributions, particularly in the development of beta-lactamase inhibitors, are pivotal in combating bacterial resistance. His patents not only represent his innovative spirit but also promise to enhance the effectiveness of existing antibiotics, ultimately benefiting global health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…